Tenaya Therapeutics

About

Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.

San Francisco,California,United States
51 - 100
http://www.tenayatherapeutics.com/

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $75M
Industries: Biopharma,Biotechnology,Health Care,Therapeutics
Founded date: Jan 1, 2016
Number Of Employee: 51 - 100
Operating Status: Active
Stock Symbol: nasdaq:TNYA
Legal Name: Tenaya Therapeutics Inc.

Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease. The company's therapies address heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration, enabling physicians to regenerate heart tissue, and additional programs focused on cardiomyopathies.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$503M

Tenaya Therapeutics has raised a total of $503M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 17, 2022	Post-IPO Equity	$75M	—	—	—	Detail
Jul 29, 2021	IPO	$180M	—	—	—	Detail
Mar 1, 2021	Series C	$106M	7	RTW Investments	—	Detail
Oct 3, 2019	Series B	$92M	4	Casdin Capital	—	Detail
Dec 6, 2016	Series A	$50M	1	The Column Group	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

8

Tenaya Therapeutics is funded by 8 investors. RTW Investments and Casdin Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
RTW Investments	Yes	Series C
Casdin Capital	—	Series C
Fidelity Management and Research Company	—	Series C
GV	—	Series C
RA Capital Management	—	Series C
T. Rowe Price	—	Series C
The Column Group	—	Series C
Greenspring Associates	—	Series B